Dr. Damanpreet Kaur Grewal, MD

Dr. Grewal practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Grewal's NPI, 1275843765, was assigned on October 18, 2010. Dr. Grewal graduated from St. George's University School of Medicine in 2009. Dr. Grewal holds California license A133855.

Dr. Grewal's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Grewal's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Grewal to 1 more hospital, named with a free account. Dr. Grewal's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grewal practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Grewal's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Grewal is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Grewal's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists acid reflux, asthma, atrial fibrillation and flutter, chronic anemia, chronic obstructive pulmonary disease (COPD), cirrhosis of the liver, gastroenteritis and gastrointestinal bleeding among the conditions Dr. Grewal treats.

CMS data shows 66 Medicare services from Dr. Grewal across 2 procedure codes in 2024, all of them office visits, for 77 Medicare patients. Medicare paid $10,332 for them. Every service was in an office.

CMS counts 77 Medicare patients who saw Dr. Grewal in 2024. The largest group is 65 to 74, with 38 patients. 74% of them have high cholesterol, and 60% have high blood pressure. 34% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Grewal's median patient age at 49, with 66% women.

In 2024, Dr. Grewal wrote 138 Medicare Part D claims for 59 patients. 68% of them were for generic drugs. CMS names the drug for 65 of them, across 4 drugs with 11 or more claims each, at $14,121 in total drug cost. In 2023, CMS named 198 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Grewal for performance year 2024, reported as part of a group. Dr. Grewal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Grewal as offering telehealth. CMS counts 25 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Grewal, more than 53% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Grewal, published from 2015 to 2021. Dr. Grewal's most frequent co-authors are Philip Nnamdi Okafor, MD, Leila Neshatian Neshatian, MD and Irene Seungwan Sonu, MD.

CMS Open Payments shows 33 general payments to Dr. Grewal from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $807.

Dr. Grewal serves on SHC Patient Safety.

Dr. Grewal graduated from St. George's University School of Medicine in 2009.

Dr. Grewal is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.